Back to Search Start Over

Long term IL-17A inhibition by secukinumab leads to reduced spinal inflammation and unchanged fatty lesions in patients with ankylosing spondylitis

Details

ISSN :
03401855
Volume :
72
Database :
OpenAIRE
Journal :
ZEITSCHRIFT FUR RHEUMATOLOGIE
Accession number :
edsair.dedup.wf.001..4de7894091759f00d4885e60200f36f6